Cargando…
Effectiveness of Eriomin® in managing hyperglycemia and reversal of prediabetes condition: A double‐blind, randomized, controlled study
This study evaluated the potential effectiveness of different doses of Eriomin® on hyperglycemia and insulin resistance associated with other metabolic biomarkers in prediabetic individuals. Prediabetes patients (n = 103, 49 ± 10 years) were randomly divided into four parallel groups: (a) Placebo; (...
Autores principales: | Ribeiro, Carolina B., Ramos, Fernanda M., Manthey, John A., Cesar, Thais B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618084/ https://www.ncbi.nlm.nih.gov/pubmed/31183921 http://dx.doi.org/10.1002/ptr.6386 |
Ejemplares similares
-
Lemon flavonoids nutraceutical (Eriomin®) attenuates prediabetes intestinal dysbiosis: A double‐blind randomized controlled trial
por: Ramos, Fernanda M. M., et al.
Publicado: (2023) -
Nutraceutical Eriocitrin (Eriomin) Reduces Hyperglycemia by Increasing Glucagon-Like Peptide 1 and Downregulates Systemic Inflammation: A Crossover-Randomized Clinical Trial
por: Cesar, Thais Borges, et al.
Publicado: (2022) -
Ayurvedic polyherbal combination (PDBT) for prediabetes: A randomized double blind placebo controlled study
por: Nakanekar, Amit, et al.
Publicado: (2019) -
Hyperglycemia-induced posterior reversible encephalopathy syndrome: A rare cause of reversible blindness
por: Dev, Nishanth, et al.
Publicado: (2019) -
Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial
por: Zhang, Xiuying, et al.
Publicado: (2017)